The relationship between prescribing expenditure and quality in primary care: An observational study

British Journal of General Practice

Volumn 56, Issue 529, 2006, Pages 613-619

  Fleetcroft, Robert ^a   Cookson, Richard ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Drug costs; Drug therapy; Primary health care; Quality indicators

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; WARFARIN;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG COST; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INFLUENZA; INFLUENZA VACCINATION; INFORMATION PROCESSING; OBSERVATIONAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; UNITED KINGDOM;

DATA COLLECTION; DRUG COSTS; DRUG PRESCRIPTIONS; ENGLAND; FAMILY PRACTICE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; QUALITY INDICATORS, HEALTH CARE;

EID: 33747058475     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Audit Commission. Primary care prescribing. A bulletin for primary care trusts. Audit Commission, London, 2003. http://www.auditcommission.gov.uk/reports/ AC-REPORT.asp?CatID=PRESS-CENTRE&ProdID=4BB73230-58A6-11d7-B28A- 0060085F8572&fromPRESS=AC-REPORT (accessed 3 Jul 2006).
2. Prescription Pricing Authority. Update on growth in prescription volume and cost year to June 2004. http://www.ppa.org.uk/pdfs/publications/volume_cost_year_jun04.pdf (accessed 11 Jul 2006).
3. Newdick C. Primary care groups and the right to prescribe. BMJ 1998; 317: 1361-1364.
4. Towse A (ed.). Guidelines for the economic evaluation of pharmaceuticals: can the UK learn form Australia and Canada? London: Office of Health Economics, 1997.
5. Smith PC, York N. Quality incentives: the case of UK general practitioners. Health Aff (Millwood) 2004; 23(3): 112-118.
6. Rice N, Dixon P, Lloyd DC, Roberts D. Derivation of a needs based capitation formula for allocating prescribing budgets to health authorities and primary care groups in England: regression analysis. BMJ 2000; 320: 284-288.
7. Prescription Pricing Authority. Prescribing drugs for asthma and COPD 2001. http://www.ppa.org.uk/news/pact-042001.htm (accessed 28 Jun 2006).
8. Greenbalgh T, Eversley J. Quality in general practicE.London Kings Fund, 1999.
9. BMA and NHS Confederation. Investing in general practice: the new General Medical Services contract (introduction). London: BMA, 2003.
10. Department of Health. Coronary heart disease. National service framework for coronary heart disease-modern standards and service models. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/ en?CONTENT_ID=4094275&chk=eTacxC (accessed 3 Jul 2006).
11. National Prescribing Centre and the National Primary Care Research and Development Centre. Modernising Medicines Management. A guide to achieving benefits for patients, professionals and the NHS. http://www.npc.co.uk/npc_pubs_mmm.htm (accessed 3 Jul 2006).
12. McColl A, Roderick P, Gabbay J, et al. Performance indicators for primary care groups: an evidence based approach. BMJ 1998; 317: 1354-1360.
13. West R. Assessment of dependence and motivation to stop smoking. BMJ 2004; 328: 338-339.
14. Kendall M. British National Formulary 47. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 2004.
15. Fleetcroft R, Cookson R. Do the incentive payments in the new NHS contract for primary care reflect likely population health gains? J Health Serv Res Policy 2006; 11 (1): 27-31.